<DOC>
	<DOCNO>NCT00542802</DOCNO>
	<brief_summary>The principal purpose study determine efficacy safety Levetiracetam versus Carbamazepine , intend number patient free crisis whole period treatment , patient affect post stroke late onset crisis .</brief_summary>
	<brief_title>Levetiracetam Versus Carbamazepine Post-Stroke Late Onset Crisis</brief_title>
	<detailed_description>Stroke common cause seizures elderly seizure among common sequela stroke . About 10 % patient experience seizure since stroke onset several year ( Silverman 2002 ) . Arbitrarly cut point 2 week divide early seizure late seizure ( Honey 2000 , Olofson 2000 , Berger 1989 ) .Late occurrence late seizure appear carry high risk epilepsy ( Wilmore 1990 ) . The risk epilepsy patient single stroke-related seizure high enough justify start anticonvulsant therapy second seizure occur ( Labovitz 2003 ) . Levetiracetam ( S-α-ethil-2-oxo-pyrrolidine acetamide ) S-enantiomer pyrrolidine derivative unrelated AED unique preclinical clinical profile ( Gower et al 1992 ) . Levetiracetam ( LEV ) bind stereospecific bind site CNS saturable reversible ( Noyer 1995 ) . This site actually know LBS Levetiracetam Binding Site ) unique correspond know receptor channel might involve neuroexcitability ( Gillard 2003 ) . LEV selectively inhibit N-type Ca2 channel CA1 pyramidal hyppocampal neuron ( Lukyanetz et 2002 ) , despite activity GABA-gated current , show potent ability reverse inhibitory effect negative allosteric modulators zinc β-carbolines GABAA glycine receptor mediate response ( Rigo et al . 2002 ) . LEV effect normal neuron ( Birnstiel et al.1997 ) LEV AEDs effect decrease repetitive neuronal firing , LEV reduce number cell fire synchronously ( amplitude ) evoke PS ( Margineau Klitgaard 2000 ) . The efficacy profile drug establish three pivotal randomize double blind , placebo control , parallel study 904 patient suffer partial seizure secondarily generalise well control previous treatment ( Shorvon et al . 2000 ; Ben-Menachem et al . 2000 ; Cereghino et al . 2000 ) .In three study LEV show significant reduction seizure frequency . A pooled analysis result three study support dose-response effect levetiracetam : responder rate 28.5 , 34.3 41.3 % patient treat levetiracetam 1000 , 2000 , 3000 mg/day respectively , compare 13.1 % placebo group . The respective value complete seizure freedom 4.7 , 6.3 , 8.6 0.8 % ( Privitera 2002 , Boon et al , 2002 ) . In review data 1422 patient treat levetiracetam , 38.6 % patient experience ≥ 50 % reduction seizure frequency 20 % experienced reduction ≥ 75 % . The present study blind one purpose study mimic daily clinical practice close possible .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>Patients stroke ( ischemic haemorrhagic ) showing ( one ) subsequent seizure 14 day 3 year stroke Patients sign informed consent form Aged ≥ 18 year Severe stroke patient Rankin scale &gt; 3 Patients life expectancy &lt; 12 month Patients screen 15 day first seizure Patients diagnose epilepsy Patients clear evidence myoclonic seizure Patients contraindication levetiracetam carbamazepine use Patients present epileptic status onset Patients MMSE &lt; 24 Patients seizure stroke Patients take AED 4 week prior randomisation study Patients show dysphagia stroke able swallow tablet . Patients low compliance study Pregnant woman , lactate sexually active woman childbearing potential use medically accept birth control method . Allergy intolerance pyrrolidine derivative and/or tablet excipients carbamazepine derivates /or tablet excipients Patients involve another clinical trial 30 day prior randomization Patients tumour Patients previous traumatic brain accident result impairment consciousness . Patients possible assess seizure onset</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>post stroke epileptic late onset seizure</keyword>
</DOC>